Daily as of 3 Nov 16:00 ET
- Price
- below both $13.43 vs 50 $15.65 / 200 $14.81
- Projection
- 💀Death cross projected in 11 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 7 May 2026 · projected 17 bars out
NVCR | NovoCureNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$13.43
+$0.22 (+1.67%)
NovoCure (NVCR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since May 2026, but the two have been closing on each other and a death cross is projected within 20 bars. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $13.15 vs 50 $14.47 / 200 $24.14
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 4 Jul 2022 · projected 30 bars out · tested 3 bars
4-hour as of 3 Nov 13:30 ET
- Price
- below both $13.50 vs 50 $14.62 / 200 $16.09
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 29 Sep 2026 · projected 14 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 29 Sep 2026 | 💀Death | 4-hour | 14 bars out | Not tested |
| 7 May 2026 | 🟨Golden moderate | daily | 17 bars out | Not tested |
| 6 May 2026 | 🟨Golden | 4-hour | 11 bars out | Not tested |
| 1 Apr 2026 | 💀Death | 4-hour | 11 bars out | Not tested |
| 24 Mar 2026 | 🟨Golden | 4-hour | 18 bars out | Not tested |
About NVCR
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$17.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid